Benchmark Holdings PLC BMK
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX 43.25
- Day Range
- GBX 43.01–43.50
- 52-Week Range
- GBX 33.15–48.00
- Bid/Ask
- GBX 0.00 / GBX 0.00
- Market Cap
- GBX 31.99 Bil
- Volume/Avg
- 40 / 97,199
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.06
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Benchmark Holdings PLC is engaged in the healthcare sector. Its operating segment includes Genetics; Advanced Nutrition; Health; and Corporate. The company generates maximum revenue from the Advanced Nutrition segment. The Advanced Nutrition segment manufactures and provides technically advanced nutrition and health products to the aquaculture industry. Geographically, it derives a majority of its revenue from Norway and also has a presence in Vietnam; the Faroe Islands; Ecuador; India; Greece; Canada; Chile, and the Rest of World.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 570
- Website
- https://www.benchmarkplc.com
Comparables
Valuation
|
Metric
|
BMK
|
W7L
|
TAM
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 27.22 | 26.80 |
Price/Book Value | 1.23 | 7.92 | 8.79 |
Price/Sales | 2.06 | 4.28 | 10.95 |
Price/Cash Flow | 38.53 | 23.30 | 25.94 |
Price/Earnings
BMK
W7L
TAM
Financial Strength
|
Metric
|
BMK
|
W7L
|
TAM
|
|---|---|---|---|
Quick Ratio | 1.33 | 1.56 | 3.62 |
Current Ratio | 2.07 | 3.52 | 3.62 |
Interest Coverage | −0.77 | 35.31 | 48.92 |
Quick Ratio
BMK
W7L
TAM
Profitability
|
Metric
|
BMK
|
W7L
|
TAM
|
|---|---|---|---|
Return on Assets (Normalized) | −4.37% | 17.40% | 26.72% |
Return on Equity (Normalized) | −7.19% | 25.29% | 34.20% |
Return on Invested Capital (Normalized) | −2.98% | 21.39% | 34.91% |
Return on Assets
BMK
W7L
TAM
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Qkzwjlgn | Jlhjzc | $70.5 Bil | |
ZTS
| Zoetis Inc Class A | Fdcxbdbqn | Nksgy | $69.4 Bil | |
HLN
| Haleon PLC ADR | Zypxbfctc | Glyr | $36.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Kwzmytwv | Rwhvw | $14.9 Bil | |
VTRS
| Viatris Inc | Qbttcxzk | Rkqy | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Tcgnzmg | Qnj | $12.0 Bil | |
CTLT
| Catalent Inc | Lfctkbm | Qdghp | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Rdnbxrynf | Ybd | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Ykldzzx | Lcyq | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Snqwydt | Gkjkb | $3.4 Bil |